Streetbeat News

Price Targets

TXN

Texas Instruments Inc. (NASDAQ:TXN) has seen a decrease in its stock price by 0.96% in the current session, 3.87% over the past month, and 13.23% over the past year. Investors are examining the company's P/E ratio, which at 22.92 is lower than the industry average of 121.95. This could indicate that the stock is undervalued or that shareholders have lower growth expectations.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 8:45 pm

NXT

Citigroup analyst Ryan Levine has maintained a Neutral rating on NEXTracker (NASDAQ:NXT) and increased the price target from $45 to $52.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 8:44 pm

DHR

Citigroup analyst Patrick Donnelly has reaffirmed a Buy rating on Danaher Corporation (NYSE:DHR) and increased the price target from $255 to $280.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 8:37 pm

SWKS

B. Riley Securities analyst Craig Ellis has maintained a Neutral rating on Skyworks Solutions (NASDAQ:SWKS) and increased the price target from $110 to $115 as reported on January 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 8:27 pm

MBUU

B. Riley Securities analyst Eric Wold has maintained a Neutral rating on Malibu Boats (NASDAQ:MBUU) but has lowered the price target from $56 to $45 as reported on January 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 8:23 pm

CSWC

B. Riley Securities analyst Bryce Rowe has maintained a Neutral rating on Capital Southwest (NASDAQ:CSWC) and increased the price target from $23.5 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 8:19 pm

OKE

In the latest quarter, 4 analysts provided mixed ratings for ONEOK (NYSE:OKE), with 1 bullish, 1 somewhat bullish, and 2 indifferent. The 12-month price targets show an average of $78.75, up 9.0% from the previous $72.25. All four analysts raised their price targets, with the highest at $85.00 and the lowest at $71.00. ONEOK's financials indicate challenges with a revenue decline of -29.17%, below-average net margin and ROE, and a debt-to-equity ratio of 1.35.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 8:00 pm

VRTX

Truist Securities analyst Robyn Karnauskas has reaffirmed a Buy rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and increased the price target from $456 to $508, as reported on January 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 7:55 pm

LXU

LSB Industries' stock (LXU) is trading lower following a downgrade by UBS from Buy to Neutral, accompanied by a reduction in the price target from $11 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 7:53 pm

PG

Truist Securities analyst Bill Chappell has maintained a Hold rating on Procter & Gamble (NYSE:PG) and increased the price target from $155 to $160 as reported on January 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 7:44 pm